Showing results (1831-1840 of 2,176) with videos related to

Sort By:
Pageof 218
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
Journal of the Royal Society, Interface|July 20, 2018
Greater wealth inequality, less polygyny: rethinking the polygyny threshold modelCody T Ross, Monique Borgerhoff Mulder, Seung-Yun Oh, et al.
Nature Aging|June 30, 2025
Nonuniversality of inflammaging across human populationsMaximilien Franck, Kamaryn T Tanner, Robert L Tennyson, et al.
JBMR Plus|October 27, 2025
Medical guidelines for fibrodysplasia ossificans progressivaFrederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 15, 2010
Association study of 182 candidate genes in anorexia nervosaAndrea Poyastro Pinheiro, Cynthia M Bulik, Laura M Thornton, et al.
Global Heart|February 11, 2015
Why did ancient people have atherosclerosis?: from autopsies to computed tomography to potential causesGregory S Thomas, L Samuel Wann, Adel H Allam, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
The Journal of Biological Chemistry|August 8, 2008
Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressivaToru Fukuda, Masakazu Kohda, Kazuhiro Kanomata, et al.
Social Science & Medicine (1982)|June 19, 2026
Exceptionally low mortality despite widespread COVID-19 infection among Indigenous Tsimane and Moseten of BoliviaLucia Inchauste, Xavier de Lamballerie, Stepháne Priet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.
Pageof 218